Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 4/2011

Open Access 01-08-2011 | Research

O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management?

Authors: Filip de Somer, John W Mulholland, Megan R Bryan, Tommaso Aloisio, Guido J Van Nooten, Marco Ranucci

Published in: Critical Care | Issue 4/2011

Login to get access

Abstract

Introduction

Acute kidney injury (AKI) is common after cardiac operations. There are different risk factors or determinants of AKI, and some are related to cardiopulmonary bypass (CPB). In this study, we explored the association between metabolic parameters (oxygen delivery (DO2) and carbon dioxide production (VCO2)) during CPB with postoperative AKI.

Methods

We conducted a retrospective analysis of prospectively collected data at two different institutions. The study population included 359 adult patients. The DO2 and VCO2 levels of each patient were monitored during CPB. Outcome variables were related to kidney function (peak postoperative serum creatinine increase and AKI stage 1 or 2). The experimental hypothesis was that nadir DO2 values and nadir DO2/VCO2 ratios during CPB would be independent predictors of AKI. Multivariable logistic regression models were built to detect the independent predictors of AKI and any kind of kidney function damage.

Results

A nadir DO2 level < 262 mL/minute/m2 and a nadir DO2/VCO2 ratio < 5.3 were independently associated with AKI within a model including EuroSCORE and CPB duration. Patients with nadir DO2 levels and nadir DO2/VCO2 ratios below the identified cutoff values during CPB had a significantly higher rate of AKI stage 2 (odds ratios 3.1 and 2.9, respectively). The negative predictive power of both variables exceeded 90%. The most accurate predictor of AKI stage 2 postoperative status was the nadir DO2 level.

Conclusions

The nadir DO2 level during CPB is independently associated with postoperative AKI. The measurement of VCO2-related variables does not add accuracy to the AKI prediction. Since DO2 during CPB is a modifiable factor (through pump flow adjustments), this study generates the hypothesis that goal-directed perfusion management aimed at maintaining the DO2 level above the identified critical value might limit the incidence of postoperative AKI.
Appendix
Available only for authorised users
Literature
1.
Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA: Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008, 23: 1970-1974. 10.1093/ndt/gfm908PubMedCrossRef
2.
Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT: Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resources utilization. Ann Intern Med 1998, 128: 194-203.PubMedCrossRef
3.
Provenchère S, Plantefève G, Hufnagel G, Vicaut E, De Vaumas C, Lecharny JB, Depoix JP, Vrtovsnik F, Desmonts JM, Philip I: Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors, and effect on clinical outcome. Anesth Analg 2003, 96: 1258-1264.PubMedCrossRef
4.
Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J: Preoperative renal risk stratification. Circulation 1997, 95: 878-884.PubMedCrossRef
5.
Llopart T, Lombardi R, Forselledo M, Andrade R: Acute renal failure in open heart surgery. Ren Fail 1997, 19: 319-323. 10.3109/08860229709026296PubMedCrossRef
6.
Wijeysundera DN, Karkouti K, Dupuis JY, Rao V, Chan CT, Granton JT, Beattie WS: Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007, 297: 1801-1809. 10.1001/jama.297.16.1801PubMedCrossRef
7.
Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U: Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 2002, 17: 401-406. 10.1191/0267659102pf610oaPubMedCrossRef
8.
Ranucci M, Romitti F, Isgrò G, Cotza M, Brozzi S, Boncilli A, Ditta A: Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg 2005, 80: 2213-2220. 10.1016/j.athoracsur.2005.05.069PubMedCrossRef
9.
Fang WC, Helm RE, Krieger KH, Rosengart TK, DuBois WJ, Sason C, Lesser ML, Isom OW, Gold JP: Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997, 96(9 suppl): II-194-II-199.
10.
Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A: Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 2003, 125: 1438-1450. 10.1016/S0022-5223(02)73291-1PubMedCrossRef
11.
Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M: The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003, 76: 784-792. 10.1016/S0003-4975(03)00558-7PubMedCrossRef
12.
Ranucci M, De Toffol B, Isgrò G, Romitti F, Conti D, Vicentini M: Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care 2006, 10: R167. 10.1186/cc5113PubMedPubMedCentralCrossRef
13.
Ranucci M, Isgrò G, Romitti F, Mele S, Biagioli B, Giomarelli P: Anaerobic metabolism during cardiopulmonary bypass: predictive value of carbon dioxide derived parameters. Ann Thorac Surg 2006, 81: 2189-2195. 10.1016/j.athoracsur.2006.01.025PubMedCrossRef
14.
Baker RA, Newland RF: Continuous quality improvement of perfusion practice: the role of electronic data collection and statistical control charts. Perfusion 2008, 23: 7-16. 10.1177/0267659108093853PubMedCrossRef
15.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network: Acute Kidney Injury Network: a report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11: R31. 10.1186/cc5713PubMedPubMedCentralCrossRef
16.
Mehta RH, Grab JD, O'Brien SM, Bridges CR, Gammie JS, Haan CK, Ferguson TB, Peterson ED: Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 2006, 114: 2208-2216. 10.1161/CIRCULATIONAHA.106.635573PubMedCrossRef
17.
Ratcliffe PJ, Endre ZH, Tange JD, Ledingham JG: Ischaemic acute renal failure: why does it occur? Nephron 1989, 52: 1-5. 10.1159/000185573PubMedCrossRef
18.
Pinsky MR: Beyond global oxygen supply-demand relations: in search of measures of dysoxia. Intensive Care Med 1994, 20: 1-3. 10.1007/BF02425045PubMedCrossRef
19.
Steltzer H, Hiesmayr M, Mayer N, Krafft P, Hammerle AF: The relationship between oxygen delivery and uptake in the critically ill: is there a critical optimal therapeutic value? A meta-analysis. Anaesthesia 1994, 49: 229-236.PubMedCrossRef
20.
Randall HM Jr, Cohen JJ: Anaerobic CO 2 production by dog kidney in vitro. Am J Physiol 1966, 211: 493-505.PubMed
21.
Lieberman JA, Weiskopf RB, Kelley SD, Feiner J, Noorani M, Leung J, Toy P, Viele M: Critical oxygen delivery in conscious humans is less than 7.3 ml . kg -1. min -1 . Anesthesiology 2000, 92: 407-413. 10.1097/00000542-200002000-00022PubMedCrossRef
22.
Zhang H, Vincent JL: Arteriovenous differences in P CO2 and pH are good indicators of critical hypoperfusion. Am Rev Respir Dis 1993, 148: 867-871. 10.1164/ajrccm/148.4_Pt_1.867PubMedCrossRef
23.
Mekontso-Dessap A, Castelain V, Anguel N, Bahloul M, Schauvliege F, Richard C, Teboul JL: Combination of venoarterial PCO 2 difference with arteriovenous O 2 content difference to detect anaerobic metabolism in patients. Intensive Care Med 2002, 28: 272-277. 10.1007/s00134-002-1215-8PubMedCrossRef
24.
Heyman SN, Khamaisi M, Rosen S, Rosenberger C: Renal parenchimal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 2008, 28: 998-1006. 10.1159/000146075PubMedCrossRef
25.
Rosenberger C, Rosen S, Heyman SN: Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006, 33: 980-988. 10.1111/j.1440-1681.2006.04472.xPubMedCrossRef
26.
Welch WJ, Baumgartl H, Lubbers D, Wilcox CS: Nephron PO 2 adrenal oxygen usage in the hypertensive rat kidney. Kidney Int 1991, 40: 632-642. 10.1038/ki.1991.255CrossRef
Metadata
Title
O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management?
Authors
Filip de Somer
John W Mulholland
Megan R Bryan
Tommaso Aloisio
Guido J Van Nooten
Marco Ranucci
Publication date
01-08-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10349

Other articles of this Issue 4/2011

Critical Care 4/2011 Go to the issue

Research

Fiber optic bronchoscopy in patients with acute hypoxemic respiratory failure requiring noninvasive ventilation - a feasibility study

Research

Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort study

Research

Manual hyperinflation partly prevents reductions of functional residual capacity in cardiac surgical patients - a randomized controlled trial

Research

Assessing left ventricular systolic function in shock: evaluation of echocardiographic parameters in intensive care

Research

'Score to Door Time', a benchmarking tool for rapid response systems: a pilot multi-centre service evaluation

Commentary

Appropriate antibiotic dosing in severe sepsis and acute renal failure: factors to consider